Post-chemotherapy arthralgia and arthritis in lung cancer

Objective: Evaluate the characteristics of arthritis, arthralgia and musculoskeletal pain after chemotherapy in patients with lung cancer. Materials and Methods: In this study, we evaluate the characteristics of 17 patients with joint symptoms following receiving chemotherapy for lung cancer. Demogr...

Full description

Bibliographic Details
Main Authors: Aref H Amiri, Soleiman Jaferian
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2012-01-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2012;volume=1;issue=2;spage=72;epage=75;aulast=Amiri
_version_ 1818391217296113664
author Aref H Amiri
Soleiman Jaferian
author_facet Aref H Amiri
Soleiman Jaferian
author_sort Aref H Amiri
collection DOAJ
description Objective: Evaluate the characteristics of arthritis, arthralgia and musculoskeletal pain after chemotherapy in patients with lung cancer. Materials and Methods: In this study, we evaluate the characteristics of 17 patients with joint symptoms following receiving chemotherapy for lung cancer. Demographic information of patients including sex, age, time of rheumatologic findings after starting of chemotherapy, time of improvement after starting of medication, and relevant laboratory findings for each patient. Results: A total of seventeen patients (six women with mean age 41.2 ± 5.2 years and 11 men with mean age 42.5 ± 8.2) that received standard chemotherapy for lung cancer according to stage of disease. Joint symptoms usually began about seven months after the first session of chemotherapy. Patients had an average of two tender joints and 1 hr of morning stiffness. Four patients were positive for anti-nuclear antibody, and none of patient was positive for rheumatoid factor. Non-steroidal anti-inflammatory drugs, disease modifying anti-rheumatic drugs (DMARD), corticosteroids, and venlafaxine were prescribed. Four patients did not show an improvement. Follow-up was available for all patients. 11 patients showed favorable responses, characterized by a significant decrease (more than 50%) in morning stiffness, pain, and tender joint counts after a mean of three months′ treatment. Two patients had complete resolution of symptoms and did not required further medications for arthritis, arthralgia or musculoskeletal pain. Conclusion: Chemotherapy-related arthropathy in lung cancer is not uncommon. Early treatment with NSAID, DMARD, and corticosteroids is effective in the majority of patients.
first_indexed 2024-12-14T05:10:01Z
format Article
id doaj.art-0cb47dcf147e4336b16f36e3b6a15be9
institution Directory Open Access Journal
issn 2278-330X
2278-4306
language English
last_indexed 2024-12-14T05:10:01Z
publishDate 2012-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series South Asian Journal of Cancer
spelling doaj.art-0cb47dcf147e4336b16f36e3b6a15be92022-12-21T23:15:59ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-43062012-01-0112727510.4103/2278-330X.103715Post-chemotherapy arthralgia and arthritis in lung cancerAref H AmiriSoleiman JaferianObjective: Evaluate the characteristics of arthritis, arthralgia and musculoskeletal pain after chemotherapy in patients with lung cancer. Materials and Methods: In this study, we evaluate the characteristics of 17 patients with joint symptoms following receiving chemotherapy for lung cancer. Demographic information of patients including sex, age, time of rheumatologic findings after starting of chemotherapy, time of improvement after starting of medication, and relevant laboratory findings for each patient. Results: A total of seventeen patients (six women with mean age 41.2 ± 5.2 years and 11 men with mean age 42.5 ± 8.2) that received standard chemotherapy for lung cancer according to stage of disease. Joint symptoms usually began about seven months after the first session of chemotherapy. Patients had an average of two tender joints and 1 hr of morning stiffness. Four patients were positive for anti-nuclear antibody, and none of patient was positive for rheumatoid factor. Non-steroidal anti-inflammatory drugs, disease modifying anti-rheumatic drugs (DMARD), corticosteroids, and venlafaxine were prescribed. Four patients did not show an improvement. Follow-up was available for all patients. 11 patients showed favorable responses, characterized by a significant decrease (more than 50%) in morning stiffness, pain, and tender joint counts after a mean of three months′ treatment. Two patients had complete resolution of symptoms and did not required further medications for arthritis, arthralgia or musculoskeletal pain. Conclusion: Chemotherapy-related arthropathy in lung cancer is not uncommon. Early treatment with NSAID, DMARD, and corticosteroids is effective in the majority of patients.http://journal.sajc.org/article.asp?issn=2278-330X;year=2012;volume=1;issue=2;spage=72;epage=75;aulast=AmiriArthritischemotherapylung cancer
spellingShingle Aref H Amiri
Soleiman Jaferian
Post-chemotherapy arthralgia and arthritis in lung cancer
South Asian Journal of Cancer
Arthritis
chemotherapy
lung cancer
title Post-chemotherapy arthralgia and arthritis in lung cancer
title_full Post-chemotherapy arthralgia and arthritis in lung cancer
title_fullStr Post-chemotherapy arthralgia and arthritis in lung cancer
title_full_unstemmed Post-chemotherapy arthralgia and arthritis in lung cancer
title_short Post-chemotherapy arthralgia and arthritis in lung cancer
title_sort post chemotherapy arthralgia and arthritis in lung cancer
topic Arthritis
chemotherapy
lung cancer
url http://journal.sajc.org/article.asp?issn=2278-330X;year=2012;volume=1;issue=2;spage=72;epage=75;aulast=Amiri
work_keys_str_mv AT arefhamiri postchemotherapyarthralgiaandarthritisinlungcancer
AT soleimanjaferian postchemotherapyarthralgiaandarthritisinlungcancer